All Pharma News
Sarepta Therapeutics to Announce First Quarter 2024 Financial Results

Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
BUSINESSWIRE
24 Apr 2024
Share Share
Sarepta Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sarepta Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BUSINESSWIRE
29 Mar 2024
Share Share
Sarepta Therapeutics Announces Call for Applications for the 2024 LGMD Grant Award Program

Sarepta Therapeutics Announces Call for Applications for the 2024 LGMD Grant Award Program
PRESS RELEASE
19 Mar 2024
Share Share
US spent $3B on DMD treatments

US spent $3B on DMD treatments
Lia DeGroot ENDPTS
12 Mar 2024
Share Share
Sarepta Therapeutics to Present at Upcoming Investor Conferences

Sarepta Therapeutics to Present at Upcoming Investor Conferences
BUSINESSWIRE
04 Mar 2024
Share Share
Sarepta Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sarepta Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BUSINESSWIRE
29 Feb 2024
Share Share
Sarepta Therapeutics Announces Call for Applications for the 7th Annual Route 79

Sarepta Therapeutics Announces Call for Applications for the 7th Annual Route 79
PRESS RELEASE
29 Feb 2024
Share Share
Elevidys gains steam amid Sarepta`s efforts to widen FDA label

Elevidys gains steam amid Sarepta`s efforts to widen FDA label
Zoey Becker FIERCE PHARMA
29 Feb 2024
Share Share
Sarepta Announces Fourth Quarter and Full-Year 2023 Financial Results

Sarepta Announces Fourth Quarter and Full-Year 2023 Financial Results
BUSINESSWIRE
28 Feb 2024
Share Share
Internal documents shed new light on Sarepta FDA decision

Internal documents shed new light on Sarepta FDA decision
ENDPTS
27 Feb 2024
Share Share